Advertisement

Topics

How To Address Unique Challenges With Generics And Process Scale-Up

12:51 EST 10 Nov 2017 | Pharmaceutical Processing

Biosimilar manufacturers are creating generic versions of biologics and beginning the process of filing for approval once they come off patent.
Contributed Author: 
Eric Resnick, Vice President and Chief Technology Officer, West Pharmaceutical Services, Inc.

Original Article: How To Address Unique Challenges With Generics And Process Scale-Up

NEXT ARTICLE

More From BioPortfolio on "How To Address Unique Challenges With Generics And Process Scale-Up"

Advertisement
Quick Search
Advertisement
Advertisement